Literature DB >> 29286867

Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.

Jesse L Berry1,2, Laura Lewis3, Emily Zolfaghari1, Sarah Green3, Bao Han A Le2,4, Thomas C Lee1,2, A Linn Murphree1,2, Jonathan W Kim1,2, Rima Jubran3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29286867      PMCID： PMC7446179          DOI： 10.1080/13816810.2017.1420807

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  9 in total

1.  Second nonocular cancers in retinoblastoma: a unified hypothesis. The Franceschetti Lecture.

Authors:  D H Abramson
Journal:  Ophthalmic Genet       Date:  1999-09       Impact factor: 1.803

2.  No association between the presence of a constitutional RB1 gene mutation and age in 68 patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; B Horsthemke
Journal:  Eur J Cancer       Date:  1999-06       Impact factor: 9.162

3.  Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation.

Authors:  Bénédicte Brichard; Michel Heusterspreute; Patrick De Potter; Christophe Chantrain; Christiane Vermylen; Catherine Sibille; Jean-Luc Gala
Journal:  Eur J Cancer       Date:  2006-01       Impact factor: 9.162

4.  Letter: Second cancers in retinoblastoma.

Authors:  L C Strong; A G Knudson
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

5.  Age at diagnosis of isolated unilateral retinoblastoma does not distinguish patients with and without a constitutional RB1 gene mutation but is influenced by a parent-of-origin effect.

Authors:  A Schüler; S Weber; M Neuhäuser; C Jurklies; T Lehnert; H Heimann; G Rudolph; K-H Jöckel; N Bornfeld; D R Lohmann
Journal:  Eur J Cancer       Date:  2005-03       Impact factor: 9.162

6.  Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.

Authors:  D H Abramson; C M Frank
Journal:  Ophthalmology       Date:  1998-04       Impact factor: 12.079

Review 7.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

Review 8.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205
  9 in total
  7 in total

1.  Conditional analysis on new tumor formation with solitary unilateral retinoblastoma in 482 consecutive patients.

Authors:  Carol L Shields; Philip W Dockery; Megan Ruben; Madalyne A Sunday; Martin Calotti; Antonio Yaghy
Journal:  Saudi J Ophthalmol       Date:  2022-06-13

2.  Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma.

Authors:  Chinh Quoc Hoang; Hong-Quan Duong; Nguyen Thanh Nguyen; Sy Anh Hao Nguyen; Cuong Nguyen; Bo Duy Nguyen; Lan Tuyet Phung; Dung Thuy Nguyen; Chau Thi Minh Pham; Trang Le Doan; Mai Hoang Tran
Journal:  Mol Clin Oncol       Date:  2021-07-03

3.  Variability in retinoblastoma genome stability is driven by age and not heritability.

Authors:  Ashley Polski; Liya Xu; Rishvanth K Prabakar; Xiaowu Gai; Jonathan W Kim; Rachana Shah; Rima Jubran; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Genes Chromosomes Cancer       Date:  2020-06-09       Impact factor: 5.006

4.  Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes.

Authors:  Liya Xu; Lishuang Shen; Ashley Polski; Rishvanth K Prabakar; Rachana Shah; Rima Jubran; Jonathan W Kim; Jacklyn Biegel; Peter Kuhn; David Cobrinik; James Hicks; Xiaowu Gai; Jesse L Berry
Journal:  Ophthalmic Genet       Date:  2020-08-17       Impact factor: 1.803

Review 5.  The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene.

Authors:  Jesse L Berry; Ashley Polski; Webster K Cavenee; Thaddeus P Dryja; A Linn Murphree; Brenda L Gallie
Journal:  Genes (Basel)       Date:  2019-11-01       Impact factor: 4.096

Review 6.  Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact.

Authors:  Carol L Shields; Zeynep Bas; Andrea Laiton; Ana Maria Velasco Silva; Ahmed Sheikh; Sara E Lally; Jerry A Shields
Journal:  Eye (Lond)       Date:  2022-02-25       Impact factor: 3.775

Review 7.  Next-Generation Technologies and Strategies for the Management of Retinoblastoma.

Authors:  Harini V Gudiseva; Jesse L Berry; Ashley Polski; Santa J Tummina; Joan M O'Brien
Journal:  Genes (Basel)       Date:  2019-12-11       Impact factor: 4.096
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.